Vikalp Vishwakarma

794 citations
20 papers · 382 indexed · h-index 11

Vikalp Vishwakarma

20 papers receiving 378 citations

Peers

Vikalp Vishwakarma
Comparison fields: 5 of 58
  • Endocrinology 79
  • Food Science 116
  • Cancer Research 73
  • Infectious Diseases 88
  • Molecular Medicine 16
Replace Medha Bhagwat with:
Medha Bhagwat United States
Karen Mungall Canada
Thomas A. Halsey United States
Helen Northen United Kingdom
Casey C. Fowler Canada
Devananda Devegowda India
Varvara K. Kozyreva United States
Magdalena Gil Uruguay
A. Hase Japan
Nadège Bossuet‐Greif France
Vikalp Vishwakarma relative to Medha Bhagwat United States Medha Bhagwat's profile →
Citations per field
00.5×3.8×
Medha Bhagwat · 1×
Citations per year

Countries citing papers authored by Vikalp Vishwakarma

Since Specialization
Citations

This map shows the geographic impact of Vikalp Vishwakarma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikalp Vishwakarma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikalp Vishwakarma more than expected).

Fields of papers citing papers by Vikalp Vishwakarma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikalp Vishwakarma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikalp Vishwakarma. The network helps show where Vikalp Vishwakarma may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Vikalp Vishwakarma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vikalp Vishwakarma Line = papers co-authored together Vikalp Vishwakarma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20258
2 202516
3 20241
4 20233
5 20239
6 20231
7 202230
8 201824
9 201825
10 201730
11 20161
12 201692
13 20158
14 20151
15 201413
16 201310
17 201225
18 201236
19 201225
20 201224

About Vikalp Vishwakarma

Vikalp Vishwakarma is a scholar working on Endocrinology, Biotechnology and Food Science, having authored 20 papers that have together received 382 indexed citations. Recurring topics across this work include Salmonella and Campylobacter epidemiology (8 papers), Viral gastroenteritis research and epidemiology (6 papers), Extracellular vesicles in disease (4 papers), Escherichia coli research studies (4 papers), Cancer Research and Treatments (3 papers), RNA Research and Splicing (3 papers), Bacteriophages and microbial interactions (2 papers) and Vibrio bacteria research studies (2 papers). The work is most often cited by research in Endocrinology (79 citations), Food Science (116 citations) and Cancer Research (73 citations). Vikalp Vishwakarma has collaborated with scholars based in United States, India and Switzerland. Frequent co-authors include Mrutyunjay Suar, Niladri Bhusan Pati, Dan A. Dixon, Ranjan Preet, Wolf‐Dietrich Hardt, Balamurugan Periaswamy, Jonathan R. Brody, Nicole Meisner‐Kober, Laura E. Stevens and Shrikant Anant. Their work appears in journals such as Cancer Research, Infection and Immunity, PLoS ONE, Virulence and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026